Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy

被引：0
|
作者：
Pietro Ferrara
Paolo A. Cortesi
Danilo Di Laura
Aldo P. Maggioni
Lorenzo G. Mantovani
机构：
[1] University of Milano-Bicocca,Center for Public Health Research
[2] IRCCS MultiMedica,Value
[3] ANMCO Research Center,Based Healthcare Unit
[4] Maria Cecilia Hospital,undefined
[5] GVM Care and Research,undefined
来源：
Clinical Drug Investigation | 2021年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：459 / 468
页数：9
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy
    Ferrara, Pietro
    Cortesi, Paolo A.
    Di Laura, Danilo
    Maggioni, Aldo P.
    Mantovani, Lorenzo G.
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 459 - 468
  • [2] Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
    Rawal, Shalin
    Sharma, Kamal
    Shah, Aditya
    Bavishi, Shriya
    Christian, Cleris
    Bhatt, Parjanya
    Konat, Ashwati
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [3] The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
    Andre Lamy
    John Eikelboom
    Wesley Tong
    Fei Yuan
    Shrikant I. Bangdiwala
    Jackie Bosch
    Stuart Connolly
    Eva Lonn
    Gilles R. Dagenais
    Kelley R. H. Branch
    Wei-Jhih Wang
    Deepak L. Bhatt
    Jeffrey Probstfield
    Georg Ertl
    Stefan Störk
    P. Gabriel Steg
    Victor Aboyans
    Isabelle Durand-Zaleski
    Lars Ryden
    Salim Yusuf
    [J]. American Journal of Cardiovascular Drugs, 2024, 24 : 117 - 127
  • [4] The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
    Lamy, Andre
    Eikelboom, John
    Tong, Wesley
    Yuan, Fei
    Bangdiwala, Shrikant I.
    Bosch, Jackie
    Connolly, Stuart
    Lonn, Eva
    Dagenais, Gilles R.
    Branch, Kelley R. H.
    Wang, Wei-Jhih
    Bhatt, Deepak L.
    Probstfield, Jeffrey
    Ertl, Georg
    Stoerk, Stefan
    Steg, P. Gabriel
    Aboyans, Victor
    Durand-Zaleski, Isabelle
    Ryden, Lars
    Yusuf, Salim
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (01) : 117 - 127
  • [5] Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
    Lee, Mei-Chuan
    Liao, Chia-Te
    Toh, Han Siong
    Chou, Chih-Chen
    Chang, Wei-Ting
    Chen, Zhih-Cherng
    Wu, Wen-Shiann
    Yu, Tsung
    Strong, Carol
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (03) : 539 - 547
  • [6] Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
    Mei-Chuan Lee
    Chia-Te Liao
    Han Siong Toh
    Chih-Chen Chou
    Wei-Ting Chang
    Zhih-Cherng Chen
    Wen-Shiann Wu
    Tsung Yu
    Carol Strong
    [J]. Cardiovascular Drugs and Therapy, 2021, 35 : 539 - 547
  • [7] Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective
    Ademi, Zanfina
    Zomer, Ella
    Tonkin, Andrew
    Liew, Danny
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 270 : 54 - 59
  • [8] COST-EFFECTIVENESS OF RIVAROXABAN AND ASPIRIN COMPARED TO ASPIRIN ALONE IN PATIENTS WITH STABLE CARDIOVASCULAR DISEASE: AN AUSTRALIAN PERSPECTIVE
    Ademi, Z.
    Zomer, E.
    Tonkin, A.
    Liew, D.
    [J]. VALUE IN HEALTH, 2018, 21 : S2 - S2
  • [9] Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone
    Rothberg, M
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (06) : 464 - 464
  • [10] Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
    Zomer, Ella
    Si, Si
    Hird, Thomas R.
    Liew, Danny
    Owen, Alice J.
    Tonkin, Andrew
    Reid, Christopher M.
    Ademi, Zanfina
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (08) : 858 - 868
12345